Andrew J. Schwab, Director, on August 19, 2026, sold 191,865 shares in Camp4 Therapeutics (CAMP) for $879,719. Following the Form 4 filing with the SEC, Schwab has control over a total of 5,677,226 common shares of the company, with 5,677,226 controlled indirectly.
SEC Filing:
Lance A Soliday, Senior Vice President & Chief Accounting Officer, on August 18, 2026, sold 2,810 shares in Expedia Group (EXPE) for $909,457. Following the Form 4 filing with the SEC, Soliday has control over a total of 12,006 common shares of the company, with 12,006 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1324424/000122520826007235/xslF345X05/doc4.xml
Rosemary Turner, Director, on August 20, 2026, sold 966 shares in Murphy USA (MUSA) for $552,436. Following the Form 4 filing with the SEC, Turner has control over a total of 449 common shares of the company, with 449 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1573516/000157351626000174/xslF345X05/form4.xml
Jocelyn Moore, Director, on August 19, 2026, sold 10,759 shares in Draftkings (DKNG) for $258,754. Following the Form 4 filing with the SEC, Moore has control over a total of 20,987 Class A common shares of the company, with 1,881 shares held directly and 19,106 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1883685/000182500626000010/xslF345X05/wk-form4_1787261639.xml